Clinical trial
Effect of Intermittent Aldesleukin Treatment With or Without Anti-HIV Drugs in…
NCT00110812 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00110812 |
|---|---|
| Title | Effect of Intermittent Aldesleukin Treatment With or Without Anti-HIV Drugs in HIV Infected People |
| Official title | STALWART: A Randomized, Open-Label, International Study of Subcutaneous Recombinant Interleukin-2 With and Without Concomitant Antiretroviral Therapy in Patients With HIV-1 Infection and CD4+ Cell Counts of 300 Cells/mm3 or More |
| Acronym | STALWART |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Collaborators | Chiron Corporation Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | IL-2 |
| Enrollment | 267 |
| Start date | Sep 1, 2005 |
| Primary completion | Feb 1, 2011 |
| Completion | Feb 1, 2011 |
| First posted | May 16, 2005 |
| Last update posted | Nov 4, 2021 |
| Countries | Argentina, Australia, Chile, Italy, Morocco, Poland, Portugal, Spain, Thailand, United Kingdom, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: